Zusammenfassung
Hintergrund
In Deutschland wenden die Krankenversicherungen derzeit alleine für die Behandlung des Dekubitus, der diabetischen Fußulzera und Ulcera cruris pro Jahr rund 5 Mrd. Euro nur an Sachkosten auf. Vor diesem Hintergrund sind Überlegungen zur ökonomischen Bedeutung der Wundbehandlung dringend erforderlich.
Methoden
Aufgrund der mangelnden evidenzgesicherten Datenlage zur Ökonomie der Wundbehandlung wird beispielhaft anhand klinischer Studien untersucht, welche Kostenrelevanz sich durch eine Umstellung von Feuchtverbänden auf andere Therapieansätze ergeben würde. Die geeigneten medizinischen Parameter werden jeweils mit den anfallenden Behandlungskosten bewertet und miteinander verglichen.
Ergebnisse
Anhand der bisher publizierten Daten können unterschiedliche Therapieansätze im Einzelfall zu einem frühzeitigeren Wundschluss mit reduzierter Komplikationsfrequenz, Verringerung von Krankenhauseinweisungen und Reduktion von Krankenhausverweiltagen führen. Trotz häufig erhöhter Tagesbehandlungskosten ergeben sich auf Grundlage solcher Daten Kostenvorteile im Vergleich zu anderen Therapiemodalitäten.
Schlussfolgerung
Obwohl aufgrund zahlreicher Faktoren wie variabler Komorbiditäten und häufiger Multimorbidität bei problematischen Wunden derzeit nur eine unzureichende Evidenz für die Effektivität und Effizienz verschiedener Modalitäten existiert, zeigt bereits die kritische Evaluation eines einzigen innovativen Therapieverfahrens im Vergleich zur Standardbehandlung, dass ein bei vordergründiger Betrachtung scheinbar teures Therapieverfahren im Einzelfall und in einem größeren ökonomischen Zusammenhang teils enorme Einsparpotenziale in sich bergen kann. Wichtig ist, die konservativen Behandlungsstrategien in operative chirurgische Konzepte einzubetten.
Abstract
Introduction
Health care insurers in Germany pay 5 billion Euros annually in materials alone for pressure ulcers, diabetic foot ulcers, and ulcus cruris. With such figures it is necessary to consider, economic aspects of treatment.
Methods
Due to the lack of evidence-based data on wound treatment costs, we investigated available studies for an effect on treatment costs when standard moist wound therapy was compared with alternative methods. Suited medical parameters are calculated and compared. Daily costs and length of treatment are correlated and compared.
Results
Published data show that alternative wound therapies may lead to an earlier wound closure, fewer complications, and reduction in hospital admissions and length of stay. Despite higher daily costs, some alternative wound therapies turn out to be more cost effective, when all economical factors are considered. In this respect a move towards alternative wound therapies could possibly lead to major savings.
Discussion
At present there is insufficient evidence to prove the efficacy of various treatment modalities for chronic wounds. This is due to numerous factors such as comorbidities and frequent multimorbidity. Nevertheless critical evaluation of one innovative treatment alone already uncovered an enormous potential for savings in a wider economic context, despite the comparatively higher cost of a single treatment. It is of utmost importance that conservative wound care become firmly embedded in surgical concepts.
Literatur
Kopp J, Wang GY, Kulmburg P et al. (2004) Accelerated wound healing by in vivo application of keratinocytes overexpressing KGF. Mol Ther 10: 86–96
Kopp J, Jeschke MG, Bach AD et al. (2004) Applied tissue engineering in the closure of severe burns and chronic wounds using cultured human autologous keratinocytes in a natural fibrin matrix. Cell Tissue Bank 5: 89–96
Voigt M, Schauer M, Schaefer DJ et al. (1999) Cultured epidermal keratinocytes on a microspherical transport system are feasible to reconstitute the epidermis in full-thickness wounds. Tissue Eng 5: 563–572
Bannasch H, Stark GB, Knam F et al. (2008) Decellularized dermis in combination with cultivated keratinocytes in a short- and long-term animal experimental investigation. J Eur Acad Dermatol Venereol 22: 41–49
Kneser U, Polykandriotis E, Ohnolz J et al. (2006) Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng 12: 1721–1731
Horch RE (2006) Future perspectives in tissue engineering. J Cell Mol Med 10: 4–6
Bleiziffer O, Eriksson E, Yao F et al. (2007) Gene transfer strategies in tissue engineering. J Cell Mol Med 11: 206–223
Stern-Straeter J, Bach AD, Stangenberg L et al. (2005) Impact of electrical stimulation on three-dimensional myoblast cultures – a real-time RT-PCR study. J Cell Mol Med 9: 883–892
Polykandriotis E, Arkudas A, Beier JP et al. (2007) Intrinsic axial vascularization of an osteoconductive bone matrix by means of an arteriovenous vascular bundle. Plast Reconstr Surg 120: 855–868
Seyhan H, Hamzavi J, Wiercinska E et al. (2006) Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med 10: 922–932
Will J, Melcher R, Treul C et al. (2008) Porous ceramic bone scaffolds for vascularized bone tissue regeneration. J Mater Sci Mater Med (in press)
Polykandriotis E, Arkudas A, Euler S et al. (2006) Prevascularisation strategies in tissue engineering. Handchir Mikrochir Plast Chir 38: 217–223
Fiegel HC, Kaufmann PM, Bruns H et al. (2007) Review: hepatic tissue engineering. J Cell Mol Med 11: 206–223
Bach AD, Beier JP, Stern-Staeter J, Horch RE (2004) Skeletal muscle tissue engineering. J Cell Mol Med 8: 413–422
Kneser U, Schaefer DJ, Polykandriotis E, Horch RE (2006) Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 10: 7–19
Munster AM (1992) Use of cultured epidermal autograft in ten patients. J Burn Care Rehabil 13: 124–126
Horch RE, Bannasch H, Kopp J et al. (1998) Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant 7: 309–317
Horch RE, Bannasch H, Stark GB (2001) Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc 33: 642–644
Horch RE, Debus M, Wagner G, Stark GB (2000) Cultured human keratinocytes on type I collagen membranes to reconstitute the epidermis. Tissue Eng 6: 53–67
Horch RE, Kopp J, Kneser U et al. (2005) Tissue engineering of cultured skin substitutes. J Cell Mol Med 9: 592–608
Horch RE, Horbach T, Lang W (2007) The nutrient omentum free flap: revascularization with vein bypasses and greater omentum flap in severe arterial ulcers. J Vasc Surg 45: 837–840
Lang W, Horch RE (2006) Distal extremity reconstruction for limb salvage in diabetic foot ulcers with pedal bypass, flap plasty and vacuum therapy. Zentralbl Chir [Suppl 1] 131: 146–150
Anderson I (2000) Quality of life and leg ulcers: will NHS reform address patient need? Br J Nurs 9: 830–832, 834, 836
Apelqvist J, Armstrong DG, Lavery LA, Boulton AJ (2008) Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. Am J Surg (in press)
Chaby G, Senet P, Vaneau M et al. (2007) Dressings for acute and chronic wounds: a systematic review. Arch Dermatol 143: 1297–1304
Dissemond J (2007) Practical consequences after MRSA identification in chronic wounds. Hautarzt 58: 952–958
Gordon L, Edwards H, Courtney M et al. (2006) A cost-effectiveness analysis of two community models of care for patients with venous leg ulcers. J Wound Care 15: 348–353
Hartmann M, Schulz D, Gundermann C, Norgauer J (2007) Economic aspects of standardization of modern wound care. Hautarzt 58: 970–974
Horch RE, Jeschke M, Loos B et al. (2003) Ulcus cruris – Chirurgische Verfahrenswahl, Debridement, Shaving, Fasziektomie, Transplantation. MedReport 27: 8–13
Queen D, Orsted H, Sanada H, Sussman G (2004) A dressing history. Int Wound J 1: 59–77
Vogt KC, Uhlyarik M, Schroeder TV (2007) Moist wound healing compared with standard care of treatment of primary closed vascular surgical wounds: a prospective randomized controlled study. Wound Repair Regen 15: 624–627
Horch RE (2004) Basics foundation and results of the vacuum therapy in the reconstructive surgery. Zentralbl Chir [Suppl 1] 129: S2–S5
Horch RE et al. (2000) Vacuum assisted closure coverage of extensive soft tissue defects and skin graft fication. ZfW J Wound Healing 5: 17–19
Kopp J, Strnad V, Bach AD et al. (2005) Vacuum application increases therapeutic safety and allows intensified local radiation treatment of malignant soft-tissue tumors. Strahlenther Onkol 181: 124–130
Loos B, Kopp J, Hohenberger W, Horch RE (2007) Post-malignancy irradiation ulcers with exposed alloplastic materials can be salvaged with topical negative pressure therapy (TNP). Eur J Surg Oncol 33: 920–925
Morykwas MJ, Argenta LC (1997) Nonsurgical modalities to enhance healing and care of soft tissue wounds. J South Orthop Assoc 6: 279–288
Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W (1997) Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 38: 553–562
Morykwas MJ, David LR, Schneider AM et al. (1999) Use of subatmospheric pressure to prevent progression of partial-thickness burns in a swine model. J Burn Care Rehabil 20: 15–21
Nord D (2006) Cost-effectiveness in wound care. Zentralbl Chir [Suppl 1] 131: 185–188
Kottner J, Mertens E, Dassen T (2007) Pressure ulcer prevalence in Germany: results of a cross-sectional study in 2006. Pflege Z 60: 28–31
Horch RE, Gerngross H, Lang W et al. (2005) Indications and safety aspects of vacuum-assisted wound closure. MMW Fortschr Med [Suppl 1] 147: 1–5
Pelka R (1997) The economic situation of chronic wounds. Krankenpfl J 35: 338
Holle G, Germann G, Sauerbier M et al. (2007) Vacuum-assisted closure therapy and wound coverage in soft tissue injury. Clinical use. Unfallchirurg 110: 289–300
Holle G, Riedel K, Gregory H von et al. (2007) Vacuum-assisted closure therapy. Current status and basic research. Unfallchirurg 110: 490–504
Philbeck TE (1999) The clinical and cost effectiveness of externally applied negative pressure wound therapy in the treatment of wounds in home healthcare medicare patients. Ostomy Wound Manage 45
Nord D (2002) Überlegungen zur Wirtschaftlichkeit der Vakuumversiegelung von Wunden mit dem VAC-Therapiesystem. Niedergelassene Chirurg 6: 1–3
Engrav LH, Heimbach DM, Reus JL et al. (1983) Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 23: 1001–1004
Freising C, Horch RE (2004) Clinical results of cultivated keratinocytes to treat burn injuries – a metaanalysis. In: Horch RE, Munster AM, Achauer BM (eds) Cultured human keratnocytes and tissue engineered skin subtitutes. Thieme – J.A. Barth, Heidelberg New York, pp 220–226
Eldad A, Stern Z, Sover H et al. (1993) The cost of an extensive burn survival. Burns 19: 235–238
Drummond MF, Sculpher MJ, Torrance GW (2005) Methods for the Economic Evaluation of Health Care Programmes. 3 edn. Oxford Univ Press, Oxford
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin: Für diese Arbeit wurden keinerlei Zuwendungen oder Unterstützungen durch die Industrie erhalten. Die Autoren wurden für Vorträge auf Kongressen durch Reisekostenübernahmen, Honorare für Vorträge u. a. in der Vergangenheit durch die Fa. KCI, Wiesbaden unterstützt; REH und ML erhalten Drittmittel von KCI USA für experimentelle Untersuchungen zu molekularen Wirkungsmechanismen der Vakuumtherapie
Author information
Authors and Affiliations
Corresponding author
Additional information
Herrn Prof. Dr. Dr. h.c. Werner Hohenberger zum 60. Geburtstag gewidmet.
Rights and permissions
About this article
Cite this article
Horch, R., Nord, D., Augustin, M. et al. Ökonomische Aspekte in der chirurgischen Wundbehandlung. Chirurg 79, 518–525 (2008). https://doi.org/10.1007/s00104-008-1500-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-008-1500-3